Clinical Trial Update: Interest of Thromboelastography (ROTEM) as a Biomarker of Revascularisation in Stroke

View source ↗

Summary

A clinical trial evaluating thromboelastography (ROTEM) as a biomarker of revascularisation in stroke; the status is unknown and no results are reported yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: University Hospital, Caen | Conditions: Stroke | Status: UNKNOWN